FDA proposes eased regulation for supplement NAC

WASHINGTON — The Food and Drug Administration is proposing a new classification for a product that’s existed in a legal gray area for years, a win for proponents of dietary supplements, including members of the MAHA movement. 

The proposed rule would classify N-acetyl-L-cysteine, known as NAC and already widely sold over the counter, as the agency’s first “Dietary Ingredient Not Excluded from the Dietary Supplement Definition” — in essence, not not a supplement. 

The need for the legal backbending stems from the fact that the FDA previously approved NAC as a drug, and FDA regulations prohibit the agency from including approved drugs in the dietary supplement category. In 1963, the agency approved NAC to break up mucus in certain lung conditions, and in 1985 to treat acetaminophen overdose. 

STAT+ Exclusive Story

STAT+





This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe